New Results Published on Pharmexa's Padre Epitope in Alzheimer's Vaccine

PharmaLive: New Results Published on Pharmexa's Padre Epitope in Alzheimer's Vaccine: "A group of scientists from the Institute of Molecular Medicine at Huntington Beach (California) and the Institute of Brain Aging and Dementia at the University of California has published new pre-clinical data on an experimental Alzheimer's vaccine incorporating Pharmexa's proprietary PADRE� epitope. The results are published in the recent edition of Vaccine (vol. 24, 2275-2282)"